secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zentalis Pharmaceuticals, Inc. (ZNTL)
CIK:        0001725160
Form:       8-K
Filed at:   2022-06-27T23:59:59+00:00
Accession:  0001725160-22-000129
Event type: leadership
Sentiment:  negative
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Chief Legal Officer Alexis M. Pinto resigns from Zentalis, effective July 5, 2022
--------------------------------------------------------------------------------

- Alexis M. Pinto notified resignation as Chief Legal Officer and Secretary on June 21, 2022.
- Resignation effective July 5, 2022; no successor named.
- Company filed Form 8-K on June 27, 2022, to report the departure.
- No reason for departure disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725160/000172516022000129/0001725160-22-000129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725160/000172516022000129/zntl-20220621.htm
  HTML page:      https://secwatch.observer/filing/0001725160-22-000129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer